Dr. Aly Abayazeed is a board-certified neuroradiologist, clinical informatician, and healthcare AI consultant with expertise spanning radiology, artificial intelligence, and medical entrepreneurship. He holds a Master’s in Clinical Informatics and Healthcare Management from Stanford Medicine and certifications in imaging and clinical informatics.

With a strong academic and clinical background, Dr. Abayazeed has held faculty positions at major institutions, such as the University of Massachusetts. He is currently a part-time associate neuroradiologist at PIH and SHARP Healthcare in California.

Beyond clinical practice, Dr. Abayazeed is the CEO of QRADAI Consultants Inc., advising radiology groups and AI startups on governance, regulatory pathways, reimbursement strategies, and clinical workflow optimization. His leadership in AI development includes pioneering FDA-cleared algorithms, such as Neosoma HGG AI for brain tumor analysis. He previously served as Chief Medical Officer at Neosoma, Inc., spearheading AI-driven neuro-oncology advancements and regulatory approvals.

Dr. Abayazeed has been a key figure in AI ethics, validation, and implementation, serving as a senior medical advisor for Paxera Health’s ARK AI platform. His contributions to radiology and AI are reflected in numerous peer-reviewed publications, patents, and invited lectures at international conferences.

A recognized thought leader, Dr. Abayazeed actively mentors at Stanford’s AI for Good Institute and has been an invited speaker at institutions such as the Congress of Neurological Surgeons and MICCAI. His research and industry contributions continue to shape the intersection of radiology and AI-driven innovation.